Business Wire
BusinessGoldman Sachs cuts or resets its 12-month view on Palantir after adjusting the target by roughly 18%The Apex TimesBusinessAhead of Mastercard earnings, a Yahoo Finance trading guide frames three market pathsThe Apex TimesBusinessUnity jumps after Google AI gaming pact, spotlighting Alphabet’s push deeper into game creation toolsThe Apex TimesBusinessTesla investors eye Oct. 12 as Cybercab display in Paris fuels robotaxi hopesThe Apex TimesBusinessTesla says China-made vehicle deliveries rose 5% in September, extending an 11-month growth streak as global sales weakenedThe Apex TimesBusinessPalantir’s meteoric run reignites the “is it too late?” question for investorsThe Apex TimesBusinessCVS Health leans into pharmacy-format experiments and Aetna’s Medicare Star Ratings as it reshapes its investment storyThe Apex TimesBusinessPfizer is spotlighted as AI adoption pressures drugmakers to prove real-world valueThe Apex TimesBusinessMeta investors focus on how AI agents could monetize, as commentary points to ‘Muse’The Apex TimesBusinessOracle warns of “force majeure” risk as AI data center power tightensThe Apex TimesBusinessBerkshire Hathaway stake in a homebuilder raises fresh questions as mortgage-qualification and margins come under strainThe Apex TimesBusinessVerizon investors are re-examining valuation as satellite competition becomes a bigger market talking pointThe Apex TimesBusinessGoldman Sachs cuts or resets its 12-month view on Palantir after adjusting the target by roughly 18%The Apex TimesBusinessAhead of Mastercard earnings, a Yahoo Finance trading guide frames three market pathsThe Apex TimesBusinessUnity jumps after Google AI gaming pact, spotlighting Alphabet’s push deeper into game creation toolsThe Apex TimesBusinessTesla investors eye Oct. 12 as Cybercab display in Paris fuels robotaxi hopesThe Apex TimesBusinessTesla says China-made vehicle deliveries rose 5% in September, extending an 11-month growth streak as global sales weakenedThe Apex TimesBusinessPalantir’s meteoric run reignites the “is it too late?” question for investorsThe Apex TimesBusinessCVS Health leans into pharmacy-format experiments and Aetna’s Medicare Star Ratings as it reshapes its investment storyThe Apex TimesBusinessPfizer is spotlighted as AI adoption pressures drugmakers to prove real-world valueThe Apex TimesBusinessMeta investors focus on how AI agents could monetize, as commentary points to ‘Muse’The Apex TimesBusinessOracle warns of “force majeure” risk as AI data center power tightensThe Apex TimesBusinessBerkshire Hathaway stake in a homebuilder raises fresh questions as mortgage-qualification and margins come under strainThe Apex TimesBusinessVerizon investors are re-examining valuation as satellite competition becomes a bigger market talking pointThe Apex TimesBusinessGoldman Sachs cuts or resets its 12-month view on Palantir after adjusting the target by roughly 18%The Apex TimesBusinessAhead of Mastercard earnings, a Yahoo Finance trading guide frames three market pathsThe Apex TimesBusinessUnity jumps after Google AI gaming pact, spotlighting Alphabet’s push deeper into game creation toolsThe Apex TimesBusinessTesla investors eye Oct. 12 as Cybercab display in Paris fuels robotaxi hopesThe Apex TimesBusinessTesla says China-made vehicle deliveries rose 5% in September, extending an 11-month growth streak as global sales weakenedThe Apex TimesBusinessPalantir’s meteoric run reignites the “is it too late?” question for investorsThe Apex TimesBusinessCVS Health leans into pharmacy-format experiments and Aetna’s Medicare Star Ratings as it reshapes its investment storyThe Apex TimesBusinessPfizer is spotlighted as AI adoption pressures drugmakers to prove real-world valueThe Apex TimesBusinessMeta investors focus on how AI agents could monetize, as commentary points to ‘Muse’The Apex TimesBusinessOracle warns of “force majeure” risk as AI data center power tightensThe Apex TimesBusinessBerkshire Hathaway stake in a homebuilder raises fresh questions as mortgage-qualification and margins come under strainThe Apex TimesBusinessVerizon investors are re-examining valuation as satellite competition becomes a bigger market talking pointThe Apex TimesBusinessGoldman Sachs cuts or resets its 12-month view on Palantir after adjusting the target by roughly 18%The Apex TimesBusinessAhead of Mastercard earnings, a Yahoo Finance trading guide frames three market pathsThe Apex TimesBusinessUnity jumps after Google AI gaming pact, spotlighting Alphabet’s push deeper into game creation toolsThe Apex TimesBusinessTesla investors eye Oct. 12 as Cybercab display in Paris fuels robotaxi hopesThe Apex TimesBusinessTesla says China-made vehicle deliveries rose 5% in September, extending an 11-month growth streak as global sales weakenedThe Apex TimesBusinessPalantir’s meteoric run reignites the “is it too late?” question for investorsThe Apex TimesBusinessCVS Health leans into pharmacy-format experiments and Aetna’s Medicare Star Ratings as it reshapes its investment storyThe Apex TimesBusinessPfizer is spotlighted as AI adoption pressures drugmakers to prove real-world valueThe Apex TimesBusinessMeta investors focus on how AI agents could monetize, as commentary points to ‘Muse’The Apex TimesBusinessOracle warns of “force majeure” risk as AI data center power tightensThe Apex TimesBusinessBerkshire Hathaway stake in a homebuilder raises fresh questions as mortgage-qualification and margins come under strainThe Apex TimesBusinessVerizon investors are re-examining valuation as satellite competition becomes a bigger market talking pointThe Apex Times
Back to front
Report: Exxon Mobil joins bidders for Shell’s U.S. chemicals assets, a potential shift for XOM’s refining-and-chemicals outlook
The Apex Times

THE APEX TIMES

Business/The Apex Times/Aug 31, 6:51 PM EDT

Report: Exxon Mobil joins bidders for Shell’s U.S. chemicals assets, a potential shift for XOM’s refining-and-chemicals outlook

Exxon Mobil Holdings has reportedly entered the race for Shell’s U.S. chemicals business, an asset package that includes four plants across Louisiana, Texas and Pennsylvania. The bid, if it proceeds, could change how investors think about XOM’s downstream growth and capital allocation.

Exxon Mobil has reportedly joined a group of bidders for Shell’s U.S. chemicals business, according to a market report published Monday by Yahoo Finance. The chemicals portfolio under consideration is described as spanning four operating plants located in Louisiana, Texas and Pennsylvania, and it is expected to move through a sales process that could reshape the downstream profile of whoever wins the assets.

The reported development matters for Exxon’s investment story because chemicals can differ from traditional refining in both demand drivers and margin volatility. While the market often tracks Exxon’s crude and product trading performance, a successful purchase of chemical manufacturing capacity would put more emphasis on XOM’s exposure to industrial demand, feedstock economics and product-cycle dynamics that are not always tightly correlated with gasoline and diesel margins.

Exxon’s potential participation also underscores the ongoing realignment in refining and chemicals, where energy majors and large industrial operators have increasingly focused on securing downstream assets that can generate more stable cash flows across cycles. In that framing, an acquisition of an established U.S. chemicals footprint would be one path to adding scale, expanding product reach, and potentially leveraging shared logistics and supply-chain expertise between refining and petrochemicals.

For investors, the core question is whether Exxon would view the assets as a strategic complement to existing operations or as a financial use of capital tied to a specific expected return. The Yahoo Finance report stops short of providing deal terms, a valuation range, or even confirmation from Exxon or Shell, instead characterizing the situation as an active bidding process that includes multiple interested parties.

The report further indicates that the deal process has been discussed in connection with a price that is “about” a certain figure, but the amount is not fully visible in the information provided here. That lack of clarity means it is not possible, from this evidence, to assess whether the expected sale price would make the transaction attractive relative to Exxon’s cash generation and its capital spending plan for refining and chemical projects.

Exxon’s downstream strategy also exists in a market context where petrochemical capacity additions and long-term demand growth are uneven by region. Securing U.S. assets could be particularly relevant if buyers believe regional production can benefit from logistics, feedstock access, and industrial customer demand, but those assumptions are not laid out in the report excerpt available for this story.

Still, major specifics remain unconfirmed. The Yahoo Finance post does not establish whether Exxon has submitted a binding bid, whether Shell has selected preferred bidders, what product slate the plants produce, or what environmental, permitting, or turnaround requirements could be associated with the acquired facilities. Without those details, it is not possible to judge the operational integration effort or the near-term cost structure changes that investors would want to see.

Going forward, market watchers will likely focus on whether Exxon makes the bid into a formal transaction and whether the buyer group expands or narrows as deadlines pass. The next meaningful milestones would be public updates from Shell regarding the sale process, any disclosure from Exxon about downstream acquisition targets, and, if a deal is announced, the terms that would allow investors to connect the purchase to expected returns and capital allocation priorities.

Why It Matters

  • A potential chemicals acquisition could change how investors value Exxon’s downstream exposure versus a refinery-heavy investment case.
  • The deal would be a test of Exxon’s willingness to deploy capital into petrochemicals capacity, which can have different margin and demand characteristics than fuels.
  • If the assets are acquired, it could influence future strategies around integration between refining and petrochemicals and how Exxon targets earnings stability across cycles.
  • Because key deal details are not disclosed here, the main market announcement is participation in a bidding process, not the likelihood or economics of a transaction.

Sources

Key Facts

  • A Yahoo Finance report says Exxon Mobil joined several bidders for Shell’s U.S. chemicals assets.
  • The assets are described as four plants in Louisiana, Texas and Pennsylvania.
  • The report characterizes the situation as part of a sales process involving multiple interested parties.
  • No confirmed deal terms, valuation range, or binding-bid status are provided in the available information.

Energy & Industrials Related

Oct 10, 4:32 AM EDT
The Apex Times

Honeywell and peers are positioned for a surge in industrial “operational technology” cybersecurity as OT systems blend with IT and regulation tightens

A new 455-page market report forecasts the operational technology security market growing from $27.39 billion in 2026 to $58.94 billion by 2031, with identity and access management expected to be the fastest-growing segment. Honeywell is among the vendors profiled, alongside Cisco, Palo Alto Networks, Fortinet and Siemens.

Honeywell and peers are positioned for a surge in industrial “operational technology” cybersecurity as OT systems blend with IT and regulation tightens
The Apex Times